Biblio Discovery — Demo Discovery Service

9 results for "Ailsa Robbins"

Showing 1–9 · 0.79 seconds · RSS

  1. Journal Article

    The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency

    Ailsa Robbins; Mathilde Bahuaud; Maxime Hentzien et al.

    Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

    BackgroundPatients with primary humoral immunodeficiency are more prone to invasive as well as recurrent pneumococcal infections. Therefore, anti-pneumococcal vaccination including the 13-valent conjugate vaccine is recommended. Nevertheless, to date, no data is available on immunogenicity of this…

  2. Journal Article

    Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection

    Juliette Romaru; Mathilde Bahuaud; Gauthier Lejeune et al.

    Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

    BackgroundPatients living with HIV (PLHIV) are prone to invasive pneumococcal disease. The 13-valent conjugated pneumococcal vaccine (PCV13) is currently recommended for all PLHIV, followed in most guidelines by a 23-valent polysaccharide pneumococcal vaccine. Data are scarce concerning the…

  3. Journal Article

    Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

    Kevin Didier; Loïs Bolko; Delphine Giusti et al.

    Frontiers in Immunology, Vol. 9 · 2018 · English · DOAJ Scopus

    Connective tissue diseases (CTDs) such as systemic lupus erythematosus, systemic sclerosis, myositis, Sjögren’s syndrome, and rheumatoid arthritis are systemic diseases which are often associated with a challenge in diagnosis. Autoantibodies (AAbs) can be detected in these diseases and help…

  4. Journal Article

    Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases

    Ailsa Robbins; Maxime Hentzien; Segolene Toquet et al.

    Frontiers in Immunology, Vol. 10 · 2019 · English · DOAJ Scopus

    Anti-SS-A antibodies are often sought for in autoimmune diseases diagnosis. Two different target proteins have actually been identified: Ro52 and Ro60. Clinical and immunological associations seem different depending on anti-Ro52 or anti-Ro60 antibodies presence. However, due to a heterogeneous…

  5. Journal Article

    Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patients

    Thierry Martin; David Launay; Thomas Barnetche et al.

    RMD Open, Vol. 10 No. 4 · 2024 · English · DOAJ Scopus

    Introduction Systemic sclerosis (SSc) is a rare autoimmune disease currently classified into two subgroups based on skin extension. The aim of this study was to determine in a large cohort whether the determination of autoantibody (AAb) profile among a full antinuclear AAbs panel including nine…

  6. Journal Article

    High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura

    Pablo Canales-Herrerias; Etienne Crickx; Matteo Broketa et al.

    The Journal of Clinical Investigation, Vol. 132 No. 12 · 2022 · English · DOAJ Scopus

    The major therapeutic goal for immune thrombocytopenic purpura (ITP) is to restore normal platelet counts using drugs to promote platelet production or by interfering with mechanisms responsible for platelet destruction. Eighty percent of patients with ITP possess anti–integrin αIIbβ3 IgG…